NORTHWEST BIOTHERAPEUTICS INC (NWBO) Operating margin 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) operating margin by fiscal year — reported operating income divided by reported revenue.
-4347.9%FY2025 · since FY2016: -12723.3% → -4347.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4347.9% | +464.6 pp |
| FY2024 | -4812.4% | -1939.4 pp |
| FY2023 | -2873.1% | +1118.7 pp |
| FY2022 | -3991.7% | +1252.2 pp |
| FY2021 | -5244.0% | +1464.4 pp |
| FY2020 | -6708.4% | -5547.4 pp |
| FY2019 | -1161.0% | +8907.2 pp |
| FY2018 | -10068.2% | +6205.0 pp |
| FY2017 | -16273.2% | -3549.9 pp |
| FY2016 | -12723.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net incomeNWBO Net marginNWBO Gross profitNWBO Gross marginNWBO Operating incomeNWBO Operating cash flowNWBO Free cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Total liabilitiesNWBO Shareholders’ equityNWBO overview →